Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 12, 2026.
The Healthcare company reported Q0 revenue of .
Anebulo Pharmaceuticals, Inc.'s stock currently trades at $0.47 with a market capitalization of $90.8M.